DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atenolol and Chlorthalidone (Atenolol / Chlorthalidone) - Published Studies

 
 



Published Studies Related to Atenolol and Chlorthalidone (Atenolol / Chlorthalidone)

Well-designed clinical trials related to Atenolol and Chlorthalidone (Atenolol / Chlorthalidone)

Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. [2003.05]

Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP). [1995.12]

Randomised double-blind comparative study of efficacy and safety of hydroflumethiazide and reserpine and chlortalidone and atenolol in the treatment of mild to moderate hypertension in black patients. [1993.10]

Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. [1991]

[A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice] [1990.04.09]

Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. [1990.03]

Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison. [1988.11]

Well-designed clinical trials possibly related to Atenolol and Chlorthalidone (Atenolol / Chlorthalidone)

Changes in serum potassium mediate thiazide-induced diabetes. [2008.12]

Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. [2008.03]

Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. [2007.11]

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. [2006.05.09]

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. [2005.01.01]

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. [2001.10.16]

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. [2001.01.01]

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). [2000.08]

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). [2000.07.26]

Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. [1998.07]

Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. [1998.06.22]

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. [1998.04.13]

Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. [1998.04]

Effect of treatment of isolated systolic hypertension on left ventricular mass. [1998.03.11]

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. [1997.07.16]

Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. [1997.01]

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. [1996.12.18]

Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. [1996.05]

[The midterm inefficacy of 2 different dosages of chlorthalidone (50 and 25 mg/day) in the regression of left ventricular mass in arterial hypertension] [1995.01]

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. [1994.10.10]

Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. [1994.10]

Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL). [1994.09]

Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly. [1994.02]

Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. [1993.08.09]

Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. [1993.04]

Left ventricular mass regression in elderly hypertensives. [1992.12]

Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. [1992.04]

[Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols] [1992.03.21]

Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. [1992.03.04]

Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group. [1992.03]

The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. [1992.01]

The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. [1992.01]

Systolic hypertension in older persons. [1992]

Effect of antihypertensives on sexual function and quality of life: the TAIM Study. [1991.04.15]

Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. [1991.02]

Special considerations in the elderly patient. [1990.12]

The effects of antihypertensive therapy on left ventricular mass in elderly patients. [1990.05.10]

Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. [1990.01.15]

Influence of left ventricular mass regression on cardiac function in hypertensive elderly individuals. [1990]

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. [1989]

The use of felodipine in the treatment of severe hypertension. [1987]

Other research related to Atenolol and Chlorthalidone (Atenolol / Chlorthalidone)

Development and validation of a reversed-phase high-performance liquid chromatographic method for the simultaneous determination of amiloride hydrochloride, atenolol, hydrochlorothiazide, and chlorthalidone in their combined mixtures. [2009.03]

Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. [2008.06]

Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms. [2003.12]

Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination. [2000.09]

Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination. [1992.06]

[The clinical profile of hypertensive patients can predict the need for combining a second or third drug with atenolol in the initial treatment of light and moderate essential arterial hypertension] [1990.09.22]

Other possibly related research studies

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. [2004.12]

Recommendations for the management of special populations: racial and ethnic populations. [2003.11]

Calcium antagonists and atherosclerosis protection in hypertension. [2003.11]

Miglustat. [2003]

The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996-2001). [2003.07]

Trandolapril: a newer angiotensin-converting enzyme inhibitor. [2003.03]

Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. [2002]

Isolated systolic hypertension: a new challenge in medicine. [2002.03]

Antihypertensive drug prescription trends at the primary health care centres in Bahrain. [2001.05]

[Intensive treatment of blood pressure in patients with kidney disease and proteinuria] [2000.10.28]

[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy] [1999]

Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. [1999.08]

Hypertension in the elderly. [1998]

Fixed combination verapamil SR/trandolapril. [1998.11]

[Intermittent fever of unknown origin] [1998.06.12]

Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). [1995.12]

[Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments] [1992.11.07]

Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. [1991.09]

Safety profile of celiprolol. [1988.11]

The statistical analysis of treatment effects in 24-hour ambulatory blood pressure recordings. [1988.06]

[Photoallergy to Neotri and cross reaction to tenoretic--detection by systemic photoprovocation] [1988.01]

Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study. [2008.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014